Abstract
Purpose
The purpose of this study was to evaluate the incidence and predictors of seed migration after transperineal interstitial prostate brachytherapy.
Materials and methods
From March 2007 to March 2011, 121 patients with stage T1–T2 prostate cancer underwent transperineal interstitial prostate brachytherapy. Pre-planning was performed 3 weeks prior to implantation, and the implants were inserted using the standard parallel needle insertion technique. All patients underwent a series of radiographs [chest radiography, kidney–ureter–bladder (KUB) radiography, and a CT scan] to assess whether seed migration had occurred on postoperative days 1 and 30, and 12 months.
Results
Seed migration occurred in 31 (25.6 %) of 121 patients. A total of 51 of 7,883 (0.65 %) implanted seeds migrated. Migration was detected on postoperative day 1 in 16 patients, day 30 in 13 patients and at 12 months in 4 patients (migration occurred at different times in 2 patients). The migrated seeds were found in the lungs, pelvis, heart, mediastinum, kidney, inguinal canal, liver and sacrum. The number of needles was a statistically significant factor in seed migration.
Conclusions
The seeds migrated to many organs. No decrease in the dose administered to the prostate or adverse effects associated with seed migration were noted.
Similar content being viewed by others
Reference
Blair HF, Porter A, Chen QS. In vivo detection of an 125I seed located in the intracardiac region after prostate permanent brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58:888–91.
Davis BJ, Bresnahan JF, Stafford SL, Karon BL, King BF, Wilson TM. Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol. 2002;168:1103.
Davis BJ, Pfeifer EA, Wilson TM, King BF, Eshleman JS, Pisansky TM. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol. 2000;164:1661.
Kunos CA, Resnick MI, Kinsella TJ, Ellis RJ. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy. 2004;3:71–7.
Older RA, Synder B, Krupski TL, Glembocki DJ, Gillenwater JY. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol. 2001;165:1590–2.
Stone NN, Stock RG. Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy. Urology. 2005;66:119–23.
Sugawara A, Nakashima J, Kunieda E, Nagata H, Mizuno R, Seki S, et al. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds. Radiat Oncol. 2011;6:130–40.
Nag S, Vivekanandam S, Martínez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;39:667–70.
Sommerkamp H, Rupprecht M, Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. Int J Radiat Oncol Biol Phys. 1988;14:389–92.
Miura N, Kusuhara Y, Numata K, Shirato A, Hashine K, Sumiyoshi Y, et al. Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung. Jpn J Clin Oncol. 2008;38:623–5.
Nguyen BD. Cardiac and hepatic seed implant embolization after prostate brachytherapy. Urology. 2006;68:673.e17–19.
Zhu AX, Wallner KE, Frivold GP, Ferry D, Jutzy KR, Foster GP. Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction. Brachytherapy. 2006;5:262–5.
Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy. 2009;8:309–12.
Nakano M, Uno H, Gotoh T, Kubota Y, Ishihara S, Deguchi T, et al. Migration of prostate brachytherapy seeds to the vertebral venous plexus. Brachytherapy. 2006;5:127–30.
Nguyen BD, Egnatios GL. Prostate brachytherapy seed migration to the left testicular vein. Brachytherapy. 2010;9:224–6.
Khurshid I, Downie GH. Pulmonary arteriovenous malformation. Postgrad Med J. 2002;78:191–7.
Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47:440–5.
Wan G, Wei Z, Gardi L, Downey DB, Fenster A. Brachytherapy needle deflection evaluation and correction. Brachyth Med Phys. 2005;32:902–9.
Wei Z, Gardi L, Downey DB, Fenster A. Oblique needle segmentation and tracking for 3D TRUS guided prostate brachytherapy. Med Phys. 2005;32:2928–41.
Sugawara A, Nakashima J, Shigematsu N, Kunieda E, Kubo A. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds. Brachytherapy. 2009;8:52–6.
Ankem MK, DeCarvalho VS, Harangozo AM, Hartanto VH, Perrotti M, Han K, et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 2002;59:555–9.
Eshleman JS, Davis BJ, Pisansky TM, Wilson TM, Haddock MG, King BF, et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys. 2004;59:419–25.
Fuller DB, Koziol JA, Feng AC. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy. 2004;3:10–9.
Merrick GS, Butler WM, Dorsey AT, Lief JH, Benson ML. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:215–20.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Miyazawa, K., Matoba, M., Minato, H. et al. Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors. Jpn J Radiol 30, 635–641 (2012). https://doi.org/10.1007/s11604-012-0102-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-012-0102-7